fiteBac™ SkinCare Promises to Make a Big Splash at the Georgia Dental Association Annual Meeting in Amelia Island, Florida

Share Article

fiteBac SkinCare, LLC, a subsidiary of a Georgia-based biotechnology company, will attend the Georgia Dental Association Annual Meeting from July 19-22 at the Ritz-Carlton in Amelia Island, Florida. fiteBac will offer samples of its highly-acclaimed Germicidal Hand Softening Gel and will have 1 oz, 3 oz, and 8 oz products available for individual and office purchase.

fiteBac SkinCare Attends Georgia Dental Association 2012 Annual Meeting

fiteBac will be the new standard for hand hygiene in the dental industry, so we are beyond excited to introduce our products at the Annual Meeting

fiteBac SkinCare announces its attendance at the upcoming Georgia Dental Association Annual Meeting in Amelia Island, Florida. The Annual Meeting offers a series of Continuing Education courses, social events, sporting events, and an Exhibit Hall, where visitors can purchase products from dozens of exhibitors. Visitors to the fiteBac exhibit will be able to sample the fiteBac SkinCare Germicidal Hand Softening Gel, a non-alcohol based hand sanitizer, and will be able to purchase 1 and 3 oz tubes, and 8 oz bottles with metered dispensers of the product.

"Our fiteBac team is ecstatic to share our products at the Georgia Dental Association Annual Meeting," said Kirk Kimmerling DDS, Marietta Dentist and founder and the CEO of Kimmerling Holdings Group, LLC, the Georgia-based biotechnology company that owns fiteBac. "The Georgia Dental Association is a prestigious organization that works tirelessly to improve oral health and to help dentists stay at the forefront of the dental industry. fiteBac will be the new standard for achieving excellence in hand hygiene practices in the dental industry, so we are beyond excited to present our products at the Annual Meeting."

fiteBac's Germicidal Hand Softening Gel has garnered enthusiastic reviews from dentists, hygienists, nurses, and healthcare professionals, who celebrate its smooth feel and sanitizing properties. Dr. John Molinari of THE DENTAL ADVISOR conducted a product analysis of the fiteBac hand gel and found that, in addition to exhibiting high levels of germicidal activity, the fiteBac Germicidal Hand Softening Gel remains on hands for eight hours, even after frequent hand washing and gloving. The results of the study have been welcome news to healthcare professionals who want to achieve excellence in hand hygiene practices and maintain strong, moisturized skin at the same time.

The Georgia Dental Association Annual Meeting will take place from July 19-22 at the Ritz-Carlton in Amelia Island, Florida. For more information, visit gadental.org.

About fiteBac™ SkinCare, LLC, and KHG: fiteBac SkinCare, LLC, is a subsidiary company of Kimmerling Holdings Group, LLC (“KHG”), a Georgia-based biotech company that has developed an antimicrobial platform intellectual property technology. KHG was founded in 2009 by Marietta dentist Kirk Kimmerling, DDS, and Dan Kearney. The two set out to create products that would "change the world, one product at a time." Kirk and Dan first targeted bacterial issues in dentistry, knowing that solving those problems would lead to dramatic improvements in oral health and, more importantly, systemic bodily health. They engaged a team of highly accomplished chemists and scientists retired from Fortune 500 companies and researchers from major universities. In doing so, KHG has developed technology with several patents pending that has application well beyond dental materials and has exciting potential in medical, plastic, composite, coating, and other applications that are in various stages of development. fiteBac SkinCare Hand Softening Gel is the first product to be released under the fiteBac brand name. To learn more about fiteBac SkinCare Germicidal Hand Softening Gel, watch fiteBac's Germicidal Hand Gel video. For more information on the cosmetic dental practice of Kirk Kimmerling DDS, click here.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Kirk Kimmerling DDS

Kirk Kimmerling CEO
Visit website